Rite Aid Foundation brings opioid education to Portland schoolsThe Rite Aid Foundation is bringing its Prescription Drug Safety Program to schools in Portland, Ore., in an attempt to curb drug abuse and misuse among teens. NCPA awaits forthcoming DIR drug pricing ruleThe National Community Pharmacists Association said it is hopeful the DIR rule will help fix pharmacy reimbursement issues. FDA issues REMS guidance to spur generic drug development The FDA has clarified several factors that determine whether a Risk Evaluation and Mitigation Strategy is required for a drug. CVS Pharmacy completes rollout of time-delay safes in Tennessee All 169 CVS Pharmacy locations in Tennessee are using time-delay safe technology. Confirm Biosciences’ HairConfirm drug test gets national distribution The product, which can test for up to 14 commonly abused drugs, has launched into CVS Pharmacy stores. Bausch + Lomb launches Lotemax SM Bausch + Lomb's Lotemax SM is designed with SubMicron technology and is indicated to treat postoperative inflammation and pain following ocular surgery. FDA aims to evaluate regulatory pathways, safety of CBD, cannabis products The FDA has set a public hearing for May 31 on the safety of cannabis products. FDA aims to drive competition on the insulin market The FDA announced a public hearing to advance access to insulin products, including biosimilar and interchangeable insulin products. Lupin debuts generic Lidex Fluocinonide ointment had a market value of roughly $15 million. Fera Pharmaceuticals gets FDA nod for Avaclyr Fera also was granted orphan drug exclusivity, providing seven years of marketing exclusivity for the product. First Previous 11 12 13 14 15 Next Last
